find a clinical trial
If you have any questions or are interested in participating in one of our Clinical Trials, please take note of the associated protocol number and contact our team at 201-518-3587, or email us.
59
Clinical Trials
Lymphoma
Phase I
Enrolling
nct/study# NCT04637763 / CB10A
A Phase 1, Multicenter, Open-Label Study of CB-010, a CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy in Patients With Relapsed/Refractory B Cell Non-Hodgkin Lymphoma (ANTLER)
Learn More
Lymphoma
N/A
Enrolling
nct/study# N/A / 2018-0227
Characteristics and Outcomes of Patients with Marginal Zone Lymphoma: A Retrospective Study
Learn More
Lymphoma
N/A
Enrolling
nct/study# N/A / CLONOSEQ-DLBCL
Real world outcomes patients with large B-cell lymphoma receiving curative intent therapies profiled with clonotype circulating tumor DNA sequencing
Learn More
Lymphoma
N/A
Enrolling
Lymphoma
Phase II
Enrolling
nct/study# NCT03113500 / COH-17058
A Phase 2 Study of Brentuximab Vedotin Plus Cyclophosphamide, Doxorubicin, Etoposide, and Prednisone (CHEP-BV) Followed by BV Consolidation in Patients with CD30-Positive Peripheral T-Cell Lymphomas
Learn More
Lymphoma
N/A
Enrolling
nct/study# N/A / 2019-0246
Outcomes of Current Front-Line Therapy Regimens in Elderly Patients with Classical Hodgkin’s Lymphoma
Learn Morewe are here for you
For more information or to schedule an appointment,
call 844-346-7222. You can also schedule an appointment by calling the RCCA location nearest you.
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.